{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:34:51Z","timestamp":1791290091568,"version":"4.3.0"},"reference-count":208,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T00:00:00Z","timestamp":1424044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.dld.2015.02.005","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T19:52:48Z","timestamp":1424375568000},"page":"443-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Role of fluorine 18 fluorodeoxyglucose positron emission tomography\/computed tomography in gastrointestinal cancers"],"prefix":"10.1016","volume":"47","author":[{"given":"Mathieu","family":"Gauth\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Richard-Molard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulfran","family":"Cacheux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Alberini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Li\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2015.02.005_bib1000","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cncr.20724","article-title":"The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of oesophageal carcinoma","volume":"103","author":"Kato","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bjc.6604200","article-title":"Staging investigations for oesophageal cancer: a meta-analysis","volume":"98","author":"Van Vliet","year":"2008","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00000658-200012000-00003","article-title":"Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the oesophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy","volume":"232","author":"Lerut","year":"2000","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1015","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1148\/radiol.2281020423","article-title":"Metastasis to regional lymph nodes in patients with oesophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study","volume":"227","author":"Yoon","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2015.02.005_bib1020","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1200\/JCO.2004.01.083","article-title":"Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in oesophageal cancer","volume":"22","author":"van Westreenen","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1025","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1200\/jco.2007.25.18_suppl.4534","article-title":"Multi-center prospective assessment of accuracy and impact on management of positron emission tomography (PET) in oesophageal and gastroesophageal junction cancers (EC). Australian PET Data Collection Project. ASCO Annual Meeting Proceedings Part I","volume":"25","author":"Chatterton","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1030","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2967\/jnumed.111.101568","article-title":"18F-FDG PET\/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of oesophageal cancer: a prospective study with mature survival data","volume":"53","author":"Barber","year":"2012","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1035","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.gassur.2004.09.040","article-title":"Adenocarcinoma of the oesophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease","volume":"8","author":"Sihvo","year":"2004","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1040","unstructured":"Th\u00e9sausus national de canc\u00e9rologie digestive. Available at: http:\/\/www.tncd.org\/ [accessed 02.02.15]."},{"key":"10.1016\/j.dld.2015.02.005_bib1045","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/bjs.7175","article-title":"Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer","volume":"97","author":"Courrech Staal","year":"2010","journal-title":"British Journal of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1050","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","article-title":"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis","volume":"12","author":"Sjoquist","year":"2011","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1055","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for oesophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1060","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the oesophagus: FFCD 9102","volume":"25","author":"Bedenne","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1065","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","article-title":"Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the oesophagus","volume":"23","author":"Stahl","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1070","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1200\/JCO.2001.19.12.3058","article-title":"Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging","volume":"19","author":"Weber","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1075","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1200\/JCO.2004.07.122","article-title":"Time course of tumour metabolic activity during chemoradiotherapy of oesophageal squamous cell carcinoma and response to treatment","volume":"22","author":"Wieder","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1080","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2005.03.033","article-title":"FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable oesophageal cancer","volume":"63","author":"Song","year":"2005","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.dld.2015.02.005_bib1085","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.sla.0000208430.07050.61","article-title":"Predictive value of 18-fluoro-deoxyglucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced oesophageal cancer","volume":"243","author":"Levine","year":"2006","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/02656730500513523","article-title":"Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET","volume":"22","author":"Westerterp","year":"2006","journal-title":"International Journal of Hyperthermia"},{"key":"10.1016\/j.dld.2015.02.005_bib1095","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1200\/JCO.2006.06.7801","article-title":"Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction","volume":"24","author":"Ott","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1100","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00259-007-0521-3","article-title":"Prediction of tumour response by PDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction","volume":"34","author":"Wieder","year":"2007","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1470-2045(07)70244-9","article-title":"PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial","volume":"8","author":"Lordick","year":"2007","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.radonc.2008.06.014","article-title":"Adenocarcinomas of the oesophagus: response to chemoradiotherapy is associated with decrease of metabolic tumour volume as measured on PET\/CT. Comparison to histopathologic and clinical response evaluation","volume":"89","author":"Roedl","year":"2008","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1115","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/SLA.0b013e3181bc9c0d","article-title":"[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in oesophageal cancer","volume":"250","author":"Vallb\u00f6hmer","year":"2009","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/SLA.0b013e3181f66596","article-title":"Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable oesophageal cancer","volume":"253","author":"van Heijl","year":"2011","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/SLA.0b013e31828676c4","article-title":"Ineffectiveness of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer","volume":"258","author":"Piessen","year":"2013","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1130","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/cncr.24399","article-title":"The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable oesophageal cancer","volume":"115","author":"Kato","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1135","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/MEG.0b013e328323d6fa","article-title":"Prognostic significance of SUV on PET\/CT in patients with oesophageal cancer: a systematic review and meta-analysis","volume":"21","author":"Pan","year":"2009","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.02.005_bib1140","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00259-013-2450-7","article-title":"The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3)","volume":"40","author":"Palie","year":"2013","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1145","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1007\/s00259-014-2839-y","article-title":"Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma","volume":"41","author":"Lemarignier","year":"2014","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2191-219X-4-12","article-title":"Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET\/CT images in patients with oesophageal cancer","volume":"4","author":"Vera","year":"2014","journal-title":"EJNMMI Research"},{"key":"10.1016\/j.dld.2015.02.005_bib1155","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1259\/bjr\/29946900","article-title":"Prognostic significance of SUV on PET\/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy\/chemoradiation: a systematic review and meta-analysis","volume":"85","author":"Zhu","year":"2012","journal-title":"British Journal of Radiology"},{"key":"10.1016\/j.dld.2015.02.005_bib1160","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2967\/jnumed.110.085803","article-title":"(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial","volume":"52","author":"zum B\u00fcschenfelde","year":"2011","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00259-012-2325-3","article-title":"Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET\/CT imaging in patients with locally advanced oesophageal carcinomas","volume":"40","author":"Cuenca","year":"2013","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1170","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1200\/JCO.2010.30.7702","article-title":"Outcomes of patients with oesophageal cancer staged with [18F]fluorodeoxyglucose positron emission tomography (FDG-PET): can post chemoradiotherapy FDG-PET predict the utility of resection","volume":"28","author":"Monjazeb","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1175","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijrobp.2005.02.039","article-title":"Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in oesophageal carcinoma","volume":"63","author":"Moureau-Zabotto","year":"2005","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.dld.2015.02.005_bib1180","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.radonc.2009.08.030","article-title":"Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for oesophageal cancer","volume":"93","author":"Muijs","year":"2009","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1185","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2006.02.014","article-title":"A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer","volume":"78","author":"Leong","year":"2006","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1190","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/bjs.4595","article-title":"Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma","volume":"91","author":"Kato","year":"2004","journal-title":"British Journal of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1195","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2967\/jnumed.106.036509","article-title":"Diagnostic and prognostic value of 18F-FDG PET\/CT for patients with suspected recurrence from squamous cell carcinoma of the oesophagus","volume":"48","author":"Guo","year":"2007","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1200","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11605-008-0749-7","article-title":"Use of positron emission tomography in surgery follow-up of oesophageal cancer","volume":"13","author":"Teyton","year":"2009","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1205","unstructured":"NCCN guidelines for utilization of PET and PET\/CT. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp [accessed 22.05.14]."},{"issue":"Suppl. 6","key":"10.1016\/j.dld.2015.02.005_bib1210","first-page":"651","article-title":"Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Stahl","year":"2013","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1215","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/MNM.0b013e32833823ac","article-title":"Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression","volume":"31","author":"Alakus","year":"2010","journal-title":"Nuclear Medicine Communications"},{"key":"10.1016\/j.dld.2015.02.005_bib1220","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00259-002-1029-5","article-title":"FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings","volume":"30","author":"Stahl","year":"2003","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1225","first-page":"690","article-title":"Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer","volume":"44","author":"Yoshioka","year":"2003","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1230","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00259-005-1887-8","article-title":"Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer","volume":"33","author":"Kim","year":"2006","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1235","first-page":"1582","article-title":"Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT","volume":"46","author":"Yun","year":"2005","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1240","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jso.21985","article-title":"The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer","volume":"104","author":"Oh","year":"2011","journal-title":"Journal of Surgical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1245","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1477-7819-8-86","article-title":"The efficacy of preoperative PET\/CT for prediction of curability in surgery for locally advanced gastric carcinoma","volume":"8","author":"Hur","year":"2010","journal-title":"World Journal of Surgical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1250","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF02984657","article-title":"Evaluation of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumour invasion, and glucose transporter-1 expression","volume":"20","author":"Yamada","year":"2006","journal-title":"Annals of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1255","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s10120-006-0374-7","article-title":"Usefulness of preoperative FDG-PET for detection of gastric cancer","volume":"9","author":"Mukai","year":"2006","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1260","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/cncr.21074","article-title":"Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography","volume":"103","author":"Chen","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1265","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10120-008-0492-5","article-title":"Imaging in assessing lymph node status in gastric cancer","volume":"12","author":"Kwee","year":"2009","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1270","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4174\/jkss.2011.81.2.104","article-title":"F18-fluorodeoxyglucose-positron emission tomography and computed tomography is not accurate in preoperative staging of gastric cancer","volume":"81","author":"Ha","year":"2011","journal-title":"Journal of the Korean Surgical Society"},{"key":"10.1016\/j.dld.2015.02.005_bib1275","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0009-9260(02)00477-4","article-title":"Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography","volume":"58","author":"Jadvar","year":"2003","journal-title":"Clinical Radiology"},{"key":"10.1016\/j.dld.2015.02.005_bib1280","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3348\/kjr.2006.7.4.249","article-title":"Comparison of CT and 18F-FDG pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma","volume":"7","author":"Lim","year":"2006","journal-title":"Korean Journal of Radiology"},{"key":"10.1016\/j.dld.2015.02.005_bib1285","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1002\/cncr.27550","article-title":"A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-d-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer","volume":"118","author":"Smyth","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1290","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1440-1746.2011.06919.x","article-title":"18F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis","volume":"27","author":"Wu","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"Suppl. 6","key":"10.1016\/j.dld.2015.02.005_bib1295","first-page":"657","article-title":"Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Waddell","year":"2013","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1300","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/BF00841409","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases","volume":"24","author":"Zimny","year":"1997","journal-title":"European Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1305","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.soc.2009.11.005","article-title":"PET and PET\/CT for pancreatic malignancies","volume":"19","author":"Delbeke","year":"2010","journal-title":"Surgical Oncology Clinics of North America"},{"key":"10.1016\/j.dld.2015.02.005_bib1310","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12149-011-0494-y","article-title":"Additional value of FDG PET\/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules","volume":"25","author":"Takanami","year":"2011","journal-title":"Annals of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1315","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00259-008-0818-x","article-title":"Diagnostic impact of 18F-FDG PET-CT evaluating solid pancreatic lesions versus endosonography, endoscopic retrograde cholangio-pancreatography with intraductal ultrasonography and abdominal ultrasound","volume":"35","author":"Schick","year":"2008","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1320","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejrad.2009.09.026","article-title":"Usefulness of 18F-FDG PET, combined FDG-PET\/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis","volume":"78","author":"Tang","year":"2011","journal-title":"European Journal of Radiology"},{"key":"10.1016\/j.dld.2015.02.005_bib1325","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MNM.0b013e328360668a","article-title":"Role of SUV(max) obtained by 18F-FDG PET\/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation","volume":"34","author":"Hu","year":"2013","journal-title":"Nuclear Medicine Communications"},{"key":"10.1016\/j.dld.2015.02.005_bib1330","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00259-004-1689-4","article-title":"FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis","volume":"32","author":"van Kouwen","year":"2005","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1335","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2214\/AJR.08.2297","article-title":"Utility of 18F-FDG PET\/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer","volume":"193","author":"Lee","year":"2009","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.dld.2015.02.005_bib1340","first-page":"447","article-title":"FDGPET\/CT findings of autoimmune pancreatitis","volume":"57","author":"Kamisawa","year":"2010","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib1345","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.crad.2007.01.023","article-title":"Positron emission tomography and computed tomography of cystic pancreatic masses","volume":"62","author":"Tann","year":"2007","journal-title":"Clinical Radiology"},{"key":"10.1016\/j.dld.2015.02.005_bib1350","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00000658-200111000-00014","article-title":"Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas","volume":"234","author":"Sperti","year":"2001","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1355","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/SLA.0b013e31815c2a29","article-title":"18-Fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas","volume":"246","author":"Sperti","year":"2007","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1360","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/SLA.0b013e3181b2fafa","article-title":"A prospective diagnostic accuracy study of (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer","volume":"250","author":"Kauhanen","year":"2009","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1365","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.sla.0000172095.97787.84","article-title":"Positron emission tomography\/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness","volume":"242","author":"Heinrich","year":"2005","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1370","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1440-1746.2010.06525.x","article-title":"Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study","volume":"26","author":"Buchs","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.02.005_bib1375","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.semnuclmed.2006.03.005","article-title":"The role of positron emission tomography in the management of pancreatic cancer","volume":"36","author":"Pakzad","year":"2006","journal-title":"Seminars in Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1380","first-page":"331","article-title":"Is combined 18F-fluorodeoxyglucose-positron emission tomography\/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?","volume":"70","author":"Casneuf","year":"2007","journal-title":"Acta Gastroenterologica Belgica"},{"key":"10.1016\/j.dld.2015.02.005_bib1385","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2967\/jnumed.108.051466","article-title":"Contrast enhanced 18F-FDG PET\/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer","volume":"49","author":"Strobel","year":"2008","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1390","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/01.mcg.0000225672.68852.05","article-title":"The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging and response evaluation after concurrent chemioradiotherapy for pancreatic cancer","volume":"40","author":"Bang","year":"2006","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib1395","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2169\/internalmedicine.48.2009","article-title":"Modalities for evaluating chemotherapeutic efficacy and survival time in patients with advanced pancreatic cancer: comparison between FDG-PET, CT, and serum tumour markers","volume":"48","author":"Kuwatani","year":"2009","journal-title":"Internal Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1400","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/003655200750023273","article-title":"Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma","volume":"35","author":"Zimny","year":"2000","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib1405","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.gassur.2003.09.002","article-title":"18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma","volume":"7","author":"Sperti","year":"2003","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1410","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijrobp.2009.06.049","article-title":"18-Fluorodeoxyglucose PET is prognostic of progression free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy","volume":"77","author":"Schellenberg","year":"2010","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.dld.2015.02.005_bib1415","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00261-011-9729-6","article-title":"Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography\/computed tomography (PET\/CT)","volume":"36","author":"Cameron","year":"2011","journal-title":"Abdominal Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1420","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2967\/jnumed.108.055780","article-title":"(18)FFDG PET\/CT for image-guided and intensity modulated radiotherapy","volume":"50","author":"Ford","year":"2009","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1425","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1748-717X-7-37","article-title":"Prognostic value of gross tumour volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy","volume":"7","author":"Parlak","year":"2012","journal-title":"Radiation Oncology"},{"issue":"Suppl. 7","key":"10.1016\/j.dld.2015.02.005_bib1430","first-page":"733","article-title":"Pancreatic adenocarcinoma: ESMO-ESDO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Seufferlein","year":"2012","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1435","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","article-title":"High and typical 18F-FDG bowel uptake in patients treated with metformin","volume":"35","author":"Gontier","year":"2008","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1440","first-page":"1804","article-title":"Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET\/CT: correlation with endoscopic and histopathologic results","volume":"45","author":"Kamel","year":"2004","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1445","first-page":"758","article-title":"PET\/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance","volume":"46","author":"Israel","year":"2005","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1450","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00259-005-0056-4","article-title":"The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT","volume":"33","author":"Even-Sapir","year":"2006","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1455","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2214\/ajr.185.2.01850495","article-title":"Incidental colonic focal lesions detected by FDG PET\/CT","volume":"185","author":"Gutman","year":"2005","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.dld.2015.02.005_bib1460","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MNM.0b013e32832999fa","article-title":"The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT","volume":"30","author":"Lee","year":"2009","journal-title":"Nuclear Medicine Communications"},{"key":"10.1016\/j.dld.2015.02.005_bib1465","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0016-5107(04)02775-0","article-title":"18-Fluorodeoxyglucose positron emission tomography has limited sensitivity for colonic adenoma and early stage colon cancer","volume":"61","author":"Friedland","year":"2005","journal-title":"Gastrointestinal Endoscopy"},{"key":"10.1016\/j.dld.2015.02.005_bib1470","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1200\/JCO.2005.02.401","article-title":"(18F)-fluoro-2-deoxy-d-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study","volume":"23","author":"VanKouwen","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1475","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.clon.2011.11.008","article-title":"Evidence-based guideline recommendations on the use of positron emission tomography imaging in colorectal cancer","volume":"24","author":"Chan","year":"2012","journal-title":"Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1480","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/MNM.0b013e328357b2d9","article-title":"A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18 F-FDG PET or PET\/CT","volume":"33","author":"Lu","year":"2012","journal-title":"Nuclear Medicine Communications"},{"key":"10.1016\/j.dld.2015.02.005_bib1485","first-page":"398","article-title":"Positron emission tomography for preoperative staging in patients with locally advanced or metastatic colorectal adenocarcinoma in lymph node metastasis","volume":"55","author":"Kosugi","year":"2008","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib1490","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1463-1318.2008.01643.x","article-title":"Comparison of preoperative whole-body positron emission tomography with MDCT in patients with primary colorectal cancer","volume":"11","author":"Akiyoshi","year":"2009","journal-title":"Colorectal Disease"},{"key":"10.1016\/j.dld.2015.02.005_bib1495","first-page":"1177","article-title":"A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer","volume":"41","author":"Huebner","year":"2000","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1500","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10350-003-0089-3","article-title":"Does positron emission tomography change management in primary rectal cancer. A prospective assessment","volume":"47","author":"Heriot","year":"2004","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.dld.2015.02.005_bib1505","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1245\/ASO.2006.04.042","article-title":"Improved staging with pretreatment positron emission tomography\/computed tomography in low rectal cancer","volume":"13","author":"Gearhart","year":"2006","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1510","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02234298","article-title":"High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study","volume":"44","author":"Wiratkapun","year":"2001","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.dld.2015.02.005_bib1515","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1477-7819-11-49","article-title":"Routine use of positron-emission tomography\/computed tomography for staging of primary colorectal cancer: does it affect clinical management?","volume":"11","author":"Cipe","year":"2013","journal-title":"World Journal of Surgical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1520","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1463-1318.2009.01873.x","article-title":"Positron emission tomography\/computed tomography (PET\/CT) in the initial staging of primary rectal cancer","volume":"12","author":"Eglinton","year":"2010","journal-title":"Colorectal Disease"},{"key":"10.1016\/j.dld.2015.02.005_bib1525","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/SLA.0000000000000525","article-title":"Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma","volume":"259","author":"Sahani","year":"2014","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1530","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/PPO.0b013e3181a58ec3","article-title":"Imaging of peritoneal carcinomatosis","volume":"15","author":"Gonz\u00e1lez-Moreno","year":"2009","journal-title":"Cancer Journal"},{"key":"10.1016\/j.dld.2015.02.005_bib1535","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jmri.22010","article-title":"Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis","volume":"31","author":"Floriani","year":"2010","journal-title":"Journal of Magnetic Resonance Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1540","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/cncr.21569","article-title":"The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases","volume":"104","author":"Wiering","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1545","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta11440","article-title":"Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers","volume":"11","author":"Facey","year":"2007","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.dld.2015.02.005_bib1550","first-page":"1797","article-title":"Direct comparison of (18) F-FDG PET and PET\/CT in patients with colorectal carcinoma","volume":"44","author":"Cohade","year":"2003","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1555","first-page":"968","article-title":"The impact of PET\/CT on therapeutic strategy of patients with colorectal cancer metastasis","volume":"56","author":"Liu","year":"2009","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib1560","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2214\/AJR.09.3205","article-title":"Assessment of tumour recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET\/CT versus contrast-enhanced 64-MDCT of the chest and abdomen","volume":"194","author":"Metser","year":"2010","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.dld.2015.02.005_bib1565","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s00259-009-1081-5","article-title":"Performance of integrated FDG PET\/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: comparison with integrated FDG PET\/non-contrast-enhanced CT and enhanced CT","volume":"36","author":"Kitajima","year":"2009","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1570","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1148\/radiol.10092440","article-title":"Role of FDG PET\/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation","volume":"258","author":"Deandreis","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2015.02.005_bib1575","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2967\/jnumed.109.063040","article-title":"Improved selection of patients for hepatic surgery of colorectal liver metastases with 18F-FDG PET: a randomized study","volume":"50","author":"Ruers","year":"2009","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1580","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2005.00.349","article-title":"Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma","volume":"23","author":"Leonard","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1585","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1245\/s10434-012-2300-z","article-title":"Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis","volume":"19","author":"van Kessel","year":"2012","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1590","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1445-2197.2009.04889.x","article-title":"Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning","volume":"79","author":"Adie","year":"2009","journal-title":"ANZ Journal of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1595","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2214\/ajr.184.4.01841096","article-title":"Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET\/CT","volume":"184","author":"Barker","year":"2005","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.dld.2015.02.005_bib1600","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/MNM.0b013e328361cd28","article-title":"Impact of 18F-FDG-PET\/CT on treatment strategy in colorectal cancer lung metastasis before lung radiofrequency ablation","volume":"34","author":"Kodama","year":"2013","journal-title":"Nuclear Medicine Communications"},{"key":"10.1016\/j.dld.2015.02.005_bib1605","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2967\/jnumed.112.119362","article-title":"The lack of evidence for PET or PET\/CT surveillance of patients with treated lymphoma, colorectal cancer, and head and neck cancer: a systematic review","volume":"54","author":"Patel","year":"2013","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1610","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MNM.0b013e32834f7dbe","article-title":"The role of 18F-FDG PET\/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels","volume":"33","author":"Ozkan","year":"2012","journal-title":"Nuclear Medicine Communications"},{"key":"10.1016\/j.dld.2015.02.005_bib1615","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.3748\/wjg.v13.i37.5025","article-title":"(18)F-DG PET\/CT in detection of recurrence and metastasis of colorectal cancer","volume":"13","author":"Chen","year":"2007","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib1620","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12149-010-0372-z","article-title":"Ability of 18F-FDG PET\/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations","volume":"24","author":"Kyoto","year":"2010","journal-title":"Annals of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1625","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00384-013-1659-z","article-title":"Use of FDG-PET or PET\/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis","volume":"28","author":"Lu","year":"2013","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1016\/j.dld.2015.02.005_bib1630","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.bjc.6604263","article-title":"Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer","volume":"98","author":"Sobhani","year":"2008","journal-title":"British Journal of Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2015.02.005_bib1635","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.2967\/jnumed.108.057224","article-title":"Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review","volume":"50","author":"de Geus-Oei","year":"2009","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1640","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/annonc\/mdr554","article-title":"Serial FDG-PET\/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy","author":"Hendlisz","year":"2012","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1645","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.3748\/wjg.v18.i36.5072","article-title":"Prognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer","volume":"18","author":"Lee","year":"2012","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib1650","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/annonc\/mdn744","article-title":"Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-d-glucose positron emission tomography in patients with advanced colorectal cancer","volume":"20","author":"Bystrom","year":"2009","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1655","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2214\/AJR.05.0902","article-title":"Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy","volume":"187","author":"Capirci","year":"2006","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.dld.2015.02.005_bib1660","first-page":"14","article-title":"Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery","volume":"47","author":"Kalff","year":"2006","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1665","first-page":"1241","article-title":"18F-FDG PET is an early predictor of pathologic tumour response to preoperative radiochemotherapy in locally advanced rectal cancer","volume":"47","author":"Cascini","year":"2006","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1670","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/ijc.27557","article-title":"18F-FDG-PET evaluation of treatment response to neo-adjuvant therapy in patients with locally advanced rectal cancer: a meta-analysis","volume":"131","author":"Zhang","year":"2012","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1675","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00259-012-2257-y","article-title":"The value of 18F-FDG PET\/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer","volume":"40","author":"Murcia Dur\u00e9ndez","year":"2013","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1680","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1002\/cncr.26644","article-title":"Accuracy of positron emission tomography\/computed tomography and clinical assessment in the detection of complete rectal tumour regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683)","volume":"118","author":"Perez","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1685","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/codi.12159","article-title":"Clinical relevance of positron emission tomography\/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation","volume":"15","author":"Perez","year":"2013","journal-title":"Colorectal Disease"},{"key":"10.1016\/j.dld.2015.02.005_bib1690","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/DCR.0b013e3182a25c4e","article-title":"Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?","volume":"56","author":"Habr-Gama","year":"2013","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.dld.2015.02.005_bib1695","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(00)04040-X","article-title":"Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery","volume":"357","author":"Beets-Tan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2015.02.005_bib1700","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00384-003-0480-5","article-title":"Rectal cancer: how accurate can imaging predict the T stage and the circumferential resection margin","volume":"18","author":"Beets-Tan","year":"2003","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1016\/j.dld.2015.02.005_bib1705","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.38937.646400.55","article-title":"Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study","volume":"333","author":"Mercury","year":"2006","journal-title":"British Medical Journal"},{"key":"10.1016\/j.dld.2015.02.005_bib1710","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.radonc.2010.07.019","article-title":"Clinical evidence on PET\u2013CT for radiation therapy planning in gastro-intestinal tumors","volume":"96","author":"Lambrecht","year":"2010","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1715","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0360-3016(03)00346-8","article-title":"Radiation treatment planning with an integrated positron emission International Journal of Surgical Oncology and computer tomography (PET\/CT): a feasibility study","volume":"57","author":"Ciernik","year":"2003","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.dld.2015.02.005_bib1720","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.radonc.2011.12.016","article-title":"FDG-PET-CT reduces the interobserver variability in rectal tumour delineation","volume":"102","author":"Buijsen","year":"2012","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1725","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2010.11.018","article-title":"FDG\u2013PET provides the best correlation with the tumour specimen compared to MRI and CT in rectal cancer","volume":"98","author":"Buijsen","year":"2011","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1730","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","article-title":"Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients \u2013 a Dutch colorectal cancer group study","volume":"23","author":"Peeters","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl. 6","key":"10.1016\/j.dld.2015.02.005_bib1735","article-title":"Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Labianca","year":"2013","journal-title":"Annals of Oncology"},{"issue":"Suppl. 5","key":"10.1016\/j.dld.2015.02.005_bib1740","first-page":"593","article-title":"Advanced colorectal cancer: ESMO clinical practice guidelines for treatment","volume":"21","author":"Van Cutsem","year":"2010","journal-title":"Annals of Oncology"},{"issue":"Suppl. 6","key":"10.1016\/j.dld.2015.02.005_bib1745","first-page":"681","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Glimelius","year":"2013","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1750","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2011.06.1955","article-title":"Positron emission tomography\/computed tomography in the staging and treatment of anal cancer","volume":"83","author":"Sveistrup","year":"2012","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.dld.2015.02.005_bib1755","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2006.01.009","article-title":"FDG-PET\/CT in the evaluation of anal carcinoma","volume":"65","author":"Cotter","year":"2006","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.dld.2015.02.005_bib1760","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2008.04.003","article-title":"Assessing the impact of FDG-PET in the management of anal cancer","volume":"87","author":"Nguyen","year":"2008","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1765","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bjc.6604897","article-title":"The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer","volume":"100","author":"de Winton","year":"2009","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1770","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11307-005-0003-6","article-title":"Positron emission tomography for pretreatment staging and post treatment evaluation in cancer of the anal canal","volume":"7","author":"Trautmann","year":"2005","journal-title":"Molecular Imaging and Biology"},{"key":"10.1016\/j.dld.2015.02.005_bib1775","first-page":"26","article-title":"Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinoma","volume":"12","author":"Iagaru","year":"2009","journal-title":"Hellenic Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1780","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.crad.2011.10.030","article-title":"PET\/CT in anal cancer \u2013 is it worth doing","volume":"67","author":"Wells","year":"2012","journal-title":"Clinical Radiology"},{"key":"10.1016\/j.dld.2015.02.005_bib1785","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijrobp.2011.10.048","article-title":"Role of positron emission tomography-computed tomography in the management of anal cancer","volume":"84","author":"Mistrangelo","year":"2012","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.dld.2015.02.005_bib1790","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijrobp.2007.02.055","article-title":"PET-CT fusion in radiation management of patients with anorectal tumors","volume":"69","author":"Anderson","year":"2007","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.dld.2015.02.005_bib1795","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.mednuc.2009.02.015","article-title":"Contribution of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in the management of anal carcinoma","volume":"33","author":"Renaud","year":"2009","journal-title":"M\u00e9decine Nucl\u00e9aire"},{"key":"10.1016\/j.dld.2015.02.005_bib1800","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.radonc.2010.02.019","article-title":"Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis","volume":"95","author":"Kidd","year":"2010","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1805","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2967\/jnumed.112.109470","article-title":"Metabolic tumour volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal","volume":"54","author":"Bazan","year":"2013","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1810","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2007.09.005","article-title":"Tumor response and survival predicted by post-therapy FDG-PET\/CT in anal cancer","volume":"71","author":"Schwarz","year":"2008","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.dld.2015.02.005_bib1815","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/bjc.2011.274","article-title":"FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy","volume":"105","author":"Day","year":"2011","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1820","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00384-010-1080-9","article-title":"Impact of FDG PET\/CT in the staging and the follow-up of anal carcinoma","volume":"26","author":"Vercellino","year":"2011","journal-title":"International Journal of Colorectal Disease"},{"key":"10.1016\/j.dld.2015.02.005_bib1825","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00261-012-9958-3","article-title":"Anal carcinoma: FDG PET\/CT in staging, response evaluation, and follow-up","volume":"38","author":"Saboo","year":"2013","journal-title":"Abdominal Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1830","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/MNM.0b013e328313bbe7","article-title":"FDG-PET and PET\/CT in the clinical management of gastrointestinal stromal tumour","volume":"29","author":"Basu","year":"2008","journal-title":"Nuclear Medicine Communications"},{"key":"10.1016\/j.dld.2015.02.005_bib1835","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clinimag.2011.08.012","article-title":"18F-fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review","volume":"36","author":"Treglia","year":"2012","journal-title":"Clinical Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1840","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1845","first-page":"17","article-title":"The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors","volume":"45","author":"Gayed","year":"2004","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1850","first-page":"357","article-title":"Comparison of PET, CT, and dual-modality PET\/CT imaging for monitoring of imatinib (ST1571) therapy in patients with gastrointestinal stromal tumors","volume":"45","author":"Antoch","year":"2004","journal-title":"Journal of Nuclear Medicine"},{"issue":"Suppl.","key":"10.1016\/j.dld.2015.02.005_bib1855","first-page":"89","article-title":"Potential role of FDG-PET to assess response to imatinib mesylate therapy and detecting viable disease in gastrointestinal stromal tumors (GIST)","volume":"45","author":"Basu","year":"2004","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1860","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00259-004-1633-7","article-title":"The value of PET, CT and in-line PET\/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate","volume":"32","author":"Goerres","year":"2005","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1865","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumour treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.02.005_bib1870","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00595-012-0411-6","article-title":"The efficacy of PET\u2013CT for predicting the malignant potential of gastrointestinal stromal tumors","volume":"43","author":"Yoshikawa","year":"2013","journal-title":"Surgery Today"},{"key":"10.1016\/j.dld.2015.02.005_bib1875","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00268-005-0045-6","article-title":"18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors","volume":"29","author":"Kamiyama","year":"2005","journal-title":"World Journal of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1880","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/00365520601040450","article-title":"Gastric GIST malignancy evaluated by 18F DG-PET as compared with EUS-FNA and endoscopic biopsy","volume":"42","author":"Yamada","year":"2007","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib1885","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5230\/jgc.2011.11.3.173","article-title":"Role of F-fluoro-2-deoxyglucose positron emission tomography in gastric GIST: predicting malignant potential pre-operatively","volume":"11","author":"Park","year":"2011","journal-title":"Journal of Gastric Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1890","first-page":"1811","article-title":"In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET","volume":"36","author":"Torizuka","year":"1995","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1895","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11307-007-0092-5","article-title":"Quantitative evaluation of 2-deoxy-2[F-18]fluoro-d-glucose-positron emission tomography imaging on the woodchuck model of hepatocellular carcinoma with histological correlation","volume":"9","author":"Salem","year":"2007","journal-title":"Molecular Imaging and Biology"},{"key":"10.1016\/j.dld.2015.02.005_bib1900","first-page":"1753","article-title":"Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass forming cholangiocarcinoma with increased (18) F-FDG uptake","volume":"46","author":"Lee","year":"2005","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1905","first-page":"1315","article-title":"Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas","volume":"51","author":"Roh","year":"2004","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib1910","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0168-8278(00)80248-2","article-title":"Positron emission tomography scanning in the evaluation of hepatocellular carcinoma","volume":"32","author":"Khan","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.02.005_bib1915","first-page":"213","article-title":"11C-acetate PET imaging in hepatocellular carcinoma and other liver masses","volume":"44","author":"Ho","year":"2003","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1920","first-page":"1128","article-title":"Hepatocellular carcinoma outcomes based on indicated treatment strategy","volume":"64","author":"Rose","year":"1998","journal-title":"American Surgeon"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2015.02.005_bib1925","first-page":"2S","article-title":"PET\/CT in cancer patient management: introduction","volume":"48","author":"Czernin","year":"2007","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.dld.2015.02.005_bib1930","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1148\/radiol.2432051244","article-title":"Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison","volume":"243","author":"Iannaccone","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2015.02.005_bib1935","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00259-009-1284-9","article-title":"FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma","volume":"37","author":"Higashi","year":"2010","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1940","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1478-3231.2011.02541.x","article-title":"Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib","volume":"31","author":"Lee","year":"2011","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2015.02.005_bib1945","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/lt.22416","article-title":"Patients with non-[18F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation","volume":"18","author":"Kornberg","year":"2012","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.dld.2015.02.005_bib1950","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1007\/s11605-011-1660-1","article-title":"The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas","volume":"15","author":"Ahn","year":"2011","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1955","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1002\/cncr.26099","article-title":"(18)F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma","volume":"117","author":"Kim","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2015.02.005_bib1960","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1007\/s00268-005-0791-5","article-title":"Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection","volume":"30","author":"Hatano","year":"2006","journal-title":"World Journal of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib1965","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00535-004-1427-5","article-title":"18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma","volume":"39","author":"Sugiyama","year":"2004","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib1970","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00259-013-2366-2","article-title":"18F-fluorodeoxyglucose PET\/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinoma","volume":"40","author":"Song","year":"2013","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.dld.2015.02.005_bib1975","first-page":"3215","article-title":"Predictive value of 18F-fluorodeoxyglucose PET\/CT for transarterial chemolipiodolization of hepatocellular carcinoma","volume":"18","author":"Song","year":"2012","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib1980","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/lt.22069","article-title":"Usefulness 18F-FDG positron emission tomography\/computed tomography for detecting recurrence of hepatocellular carcinoma in post-transplant patients","volume":"16","author":"Kim","year":"2010","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.dld.2015.02.005_bib1985","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/lt.20861","article-title":"The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients","volume":"12","author":"Yang","year":"2006","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.dld.2015.02.005_bib1990","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.transproceed.2009.06.115","article-title":"Increased 18F-FDG uptake of hepatocellular carcinoma on positron emission tomography independently predicts tumour recurrence in liver transplant patients","volume":"41","author":"Kornberg","year":"2009","journal-title":"Transplantation Proceedings"},{"key":"10.1016\/j.dld.2015.02.005_bib1995","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1572-0241.2007.01710.x","article-title":"Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging","volume":"103","author":"Kim","year":"2008","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.02.005_bib2000","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhep.2006.03.009","article-title":"Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma","volume":"45","author":"Petrowsky","year":"2006","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2015.02.005_bib2005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.rct.0000237811.88251.d7","article-title":"[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma","volume":"31","author":"Jadvar","year":"2007","journal-title":"Journal of Computer Assisted Tomography"},{"key":"10.1016\/j.dld.2015.02.005_bib2010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.surg.2008.01.010","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma","volume":"143","author":"Seo","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib2015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1440-1746.2007.05173.x","article-title":"Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas","volume":"23","author":"Moon","year":"2008","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2015.02.005_bib2020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2007.07.002","article-title":"18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer","volume":"206","author":"Corvera","year":"2008","journal-title":"Journal of the American College of Surgeons"},{"key":"10.1016\/j.dld.2015.02.005_bib2025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gassur.2003.10.003","article-title":"Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma","volume":"8","author":"Anderson","year":"2004","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib2030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.amjsurg.2003.12.070","article-title":"Positron-emission tomography with fluorine-18-fluoro-2-deoxy-d-glucose for gallbladder cancer diagnosis","volume":"188","author":"Rodr\u00edguez-Fern\u00e1ndez","year":"2004","journal-title":"American Journal of Surgery"},{"key":"10.1016\/j.dld.2015.02.005_bib2035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jso.10295","article-title":"Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluorodeoxyglucose (FDG-PET)","volume":"84","author":"Koh","year":"2003","journal-title":"Journal of Surgical Oncology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815002145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815002145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T06:33:40Z","timestamp":1651300420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865815002145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":208,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1590865815002145"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2015.02.005","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of fluorine 18 fluorodeoxyglucose positron emission tomography\/computed tomography in gastrointestinal cancers","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2015.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}